Showing results (51-60 of 499) with videos related to
Sort By:
Pageof 50
Drugs|August 25, 2010
Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and resultsBabafemi Taiwo, Robert L Murphy, Christine KatlamaAIDS (London, England)|March 18, 2011
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patientsVictor Appay, Solène Fastenackels, Christine Katlama, et al.AIDS (London, England)|June 12, 2003
The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patientsBéhazine Combadière, Sophie Faure, Brigitte Autran, et al.Frontiers in Immunology|July 29, 2020
Cell-Mediated Immune Responses to COVID-19 InfectionAmélie Guihot, Elena Litvinova, Brigitte Autran, et al.Presse Medicale (Paris, France : 1983)|September 25, 2003
[Antiretroviral-induced toxiderma in HIV-infected patients]Eric Caumes, Philippe Bossi, Christine Katlama, et al.Journal of Immunological Methods|October 9, 2007
Cell permeabilization for the assessment of T lymphocyte polyfunctional capacityLaura Papagno, Jorge R Almeida, Elisa Nemes, et al.Experimental Gerontology|February 20, 2007
Accelerated immune senescence and HIV-1 infectionVictor Appay, Jorge R Almeida, Delphine Sauce, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 6, 2013
Adjustment of antiretroviral regimen may lead to HBV reactivation even in patients with past HBV infection serological profileSophie Seang, Vincent Thibault, Marc Antoine Valantin, et al.Plos Pathogens|May 19, 2011
CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitopeSylvain Cardinaud, Gesa Consiglieri, Romain Bouziat, et al.Bulletin Du Cancer|February 4, 2006
[Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives]Jean-Philippe Spano, Guislaine Carcelain, Christine Katlama, et al.Pageof 50